Targeted Therapies for Soft Tissue Sarcoma: New Horizons in Treatment
Received Date: Sep 02, 2023 / Accepted Date: Sep 29, 2023 / Published Date: Sep 29, 2023
Abstract
Soft tissue sarcoma (STS) encompasses a diverse group of rare and challenging malignancies originating from soft tissues. Historically, treatment options have been limited to surgery, radiation, and chemotherapy, often yielding suboptimal outcomes. However, the emergence of targeted therapies has revolutionized the landscape of STS treatment, offering new horizons and renewed hope for patients and clinicians alike. Targeted therapies represent a class of treatments designed to selectively target specific molecular abnormalities or pathways essential for tumor growth and survival. By honing in on these unique molecular targets, targeted therapies aim to achieve higher efficacy with reduced systemic toxicity compared to conventional chemotherapy.
Keywords: Soft tissue sarcoma; Surgery; Radiation; Chemotherapy; Toxicity
Citation: Moorish R (2023) Targeted Therapies for Soft Tissue Sarcoma: New Horizons in Treatment. J Orthop Oncol 9: 224. Doi: 10.4172/2472-016X.1000224
Copyright: © 2023 Moorish R. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
Recommended Journals
天美传媒 Access Journals
Article Tools
Article Usage
- Total views: 614
- [From(publication date): 0-2023 - Jan 10, 2025]
- Breakdown by view type
- HTML page views: 545
- PDF downloads: 69
